| A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer R Hitt, JJ Grau, A López-Pousa, A Berrocal, C García-Girón, A Irigoyen, ... Annals of Oncology 25 (1), 216-225, 2014 | 380 | 2014 |
| Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy … P Blanchard, J Bourhis, B Lacas, MR Posner, JB Vermorken, ... Journal of clinical oncology 31 (23), 2854-2860, 2013 | 342 | 2013 |
| Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group B Lacas, A Carmel, C Landais, SJ Wong, L Licitra, JS Tobias, B Burtness, ... Radiotherapy and Oncology 156, 281-293, 2021 | 282 | 2021 |
| Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head … R Hitt, A Irigoyen, H Cortes-Funes, JJ Grau, JA García-Sáenz, ... Annals of Oncology 23 (4), 1016-1022, 2012 | 233 | 2012 |
| Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: A high proportion of mutations unique to Spain and evidence of founder effects O Díez, A Osorio, M Durán, JI Martinez‐Ferrandis, M Hoya, R Salazar, ... Human mutation 22 (4), 301-312, 2003 | 224 | 2003 |
| Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell … J Guigay, A Aupérin, J Fayette, E Saada-Bouzid, C Lafond, M Taberna, ... The Lancet Oncology 22 (4), 463-475, 2021 | 159 | 2021 |
| Liquid biopsy as novel tool in precision medicine: Origins, properties, identification and clinical perspective of cancer’s biomarkers D Fernández-Lázaro, JL García Hernández, AC García, ... Diagnostics 10 (4), 215, 2020 | 130 | 2020 |
| Reversible posterior leukoencephalopathy syndrome induced by sunitinib G Martín, L Bellido, JJ Cruz Journal of Clinical Oncology 25 (23), 3559-3559, 2007 | 129 | 2007 |
| Final results of a randomized phase III trial comparing induction chemotherapy with cisplatin/5-FU or docetaxel/cisplatin/5-FU follow by chemoradiotherapy (CRT) versus CRT … R Hitt, JJ Grau, A Lopez-Pousa, A Berrocal, C Garcia Giron, A Irigoyen, ... Journal of Clinical Oncology 27 (15_suppl), 6009-6009, 2009 | 104 | 2009 |
| Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based … International journal of epidemiology 47 (3), 872-883i, 2018 | 99 | 2018 |
| Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics ÁL Montejo, C Arango, M Bernardo, JL Carrasco, B Crespo-Facorro, ... Frontiers in Neuroendocrinology 45, 25-34, 2017 | 99 | 2017 |
| SEOM clinical guidelines for the treatment of head and neck cancer (2020) R Mesia, L Iglesias, J Lambea, J Martínez-Trufero, A Soria, M Taberna, ... Clinical and Translational Oncology 23, 913-921, 2021 | 98 | 2021 |
| Evaluation of multiparameter flow cytometry for the detection of breast cancer tumor cells in blood samples I Cruz, J Ciudad, JJ Cruz, M Ramos, A Gómez-Alonso, JC Adansa, ... American journal of clinical pathology 123 (1), 66-74, 2005 | 94 | 2005 |
| E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma AS García, MMA Hernández, EF Sánchez, RJ Gonzalez, PG Villardón, ... Medicina oral, patología oral y cirugía bucal. Ed. inglesa 11 (2), 1, 2006 | 91 | 2006 |
| Neuregulin expression modulates clinical response to trastuzumab in patients with metastatic breast cancer E de Alava, A Ocana, M Abad, JC Montero, A Esparís-Ogando, ... Journal of Clinical Oncology 25 (19), 2656-2663, 2007 | 84 | 2007 |
| The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO) RA Popescu, R Schäfer, R Califano, R Eckert, R Coleman, JY Douillard, ... Annals of oncology 25 (1), 9-15, 2014 | 83 | 2014 |
| Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification C Heneghan, C Blacklock, R Perera, R Davis, A Banerjee, P Gill, S Liew, ... BMJ open 3 (7), e003298, 2013 | 76 | 2013 |
| Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia ÁL Montejo, C Arango, M Bernardo, JL Carrasco, B Crespo-Facorro, ... Revista de Psiquiatría y Salud Mental (English Edition) 9 (3), 158-173, 2016 | 72 | 2016 |
| Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis C Petit, B Lacas, JP Pignon, QT Le, V Grégoire, C Grau, A Hackshaw, ... The Lancet Oncology 22 (5), 727-736, 2021 | 70 | 2021 |
| Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment J Martinez-Trufero, D Isla, JC Adansa, A Irigoyen, R Hitt, I Gil-Arnaiz, ... British journal of cancer 102 (12), 1687-1691, 2010 | 67 | 2010 |
ROGELIO GONZÁLEZ-SARMIENTOUniversity of SalamancaVerified email at usal.es
